Literature DB >> 16912319

The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms.

Andreas Müller-Schiffmann1, Julia Beckmann, Gertrud Steger.   

Abstract

The expression of the proteins encoded by human papillomaviruses (HPVs) is tightly linked to the differentiation program of the infected keratinocytes. The late promoter, expressing the structural proteins, becomes activated in the differentiated keratinocytes, while the early promoter is also active in the basal layers. We have shown previously that the viral transcriptional regulator E2 and the cellular coactivator p300 cooperate in activation of gene expression of HPV8, which infects the skin and is associated with epidermodysplasia verruciformis. Here we demonstrate that this activation is further stimulated after overexpression of the E6 oncoprotein of HPV8 (8E6). RNase protection experiments revealed that 8E6 efficiently cooperates with 8E2 and p300 in activation of the late promoter. In addition, the early promoter, which did not respond to 8E2 and/or p300, was stimulated more than fourfold by 8E6. Our data suggest that both promoters are activated via distinct mechanisms, since the activation of the early promoter was achieved by the N-terminal moiety of 8E6; in contrast, its C-terminal half was sufficient for late promoter activation. This was markedly reduced by the deletion of amino acids 132 to 136 of 8E6, which also abolished the binding to p300, indicating that a direct interaction between 8E6 and p300 is involved. Moreover, a 45-amino-acid segment within the C/H3 region of p300 is required for 8E6 to stimulate the coactivator function of p300. Our results demonstrate for the first time that an E6 oncoprotein of HPV directly contributes to the regulation of HPV gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912319      PMCID: PMC1563847          DOI: 10.1128/JVI.00250-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Interaction and functional collaboration of p300 and C/EBPbeta.

Authors:  S Mink; B Haenig; K H Klempnauer
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  Competitive binding of viral E2 protein and mammalian core-binding factor to transcriptional control sequences of human papillomavirus type 8 and bovine papillomavirus type 1.

Authors:  H M Schmidt; G Steger; H Pfister
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.

Authors:  M Merika; A J Williams; G Chen; T Collins; D Thanos
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

4.  A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential.

Authors:  M Elbel; S Carl; S Spaderna; T Iftner
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

5.  Synergistic activation of transcription by CBP and p53.

Authors:  W Gu; X L Shi; R G Roeder
Journal:  Nature       Date:  1997-06-19       Impact factor: 49.962

6.  Binding and modulation of p53 by p300/CBP coactivators.

Authors:  N L Lill; S R Grossman; D Ginsberg; J DeCaprio; D M Livingston
Journal:  Nature       Date:  1997-06-19       Impact factor: 49.962

Review 7.  Role of HPV in cutaneous premalignant and malignant tumors.

Authors:  H Pfister; J Ter Schegget
Journal:  Clin Dermatol       Date:  1997 May-Jun       Impact factor: 3.541

8.  Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.

Authors:  I Kitabayashi; A Yokoyama; K Shimizu; M Ohki
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

9.  Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.

Authors:  T P Yao; S P Oh; M Fuchs; N D Zhou; L E Ch'ng; D Newsome; R T Bronson; E Li; D M Livingston; R Eckner
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

10.  Regulatory interactions of transcription factor YY1 with control sequences of the E6 promoter of human papillomavirus type 8.

Authors:  H S Pajunk; C May; H Pfister; P G Fuchs
Journal:  J Gen Virol       Date:  1997-12       Impact factor: 3.891

View more
  20 in total

1.  Human papillomavirus type 8 E6 oncoprotein inhibits transcription of the PDZ protein syntenin-2.

Authors:  Daliborka Lazić; Martin Hufbauer; Paola Zigrino; Stephanie Buchholz; Siamaque Kazem; Mariet C W Feltkamp; Cornelia Mauch; Gertrud Steger; Herbert Pfister; Baki Akgül
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 2.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

3.  The human papillomavirus type 8 E6 protein interferes with NOTCH activation during keratinocyte differentiation.

Authors:  Jordan M Meyers; Jennifer M Spangle; Karl Munger
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

Review 4.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

Authors:  Raffaella Ghittoni; Rosita Accardi; Uzma Hasan; Tarik Gheit; Bakary Sylla; Massimo Tommasino
Journal:  Virus Genes       Date:  2009-10-17       Impact factor: 2.332

5.  HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition.

Authors:  Nicholas A Wallace; Stephen L Gasior; Zachary J Faber; Heather L Howie; Prescott L Deininger; Denise A Galloway
Journal:  Virology       Date:  2013-05-23       Impact factor: 3.616

6.  Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability.

Authors:  Nicholas A Wallace; Kristin Robinson; Denise A Galloway
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

7.  Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association.

Authors:  Heather L Howie; Jennifer I Koop; Joleen Weese; Kristin Robinson; Greg Wipf; Leslie Kim; Denise A Galloway
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

Review 8.  Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer.

Authors:  Rabia Faridi; Amreen Zahra; Khalida Khan; Muhammad Idrees
Journal:  Virol J       Date:  2011-06-03       Impact factor: 4.099

9.  HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage.

Authors:  Nicholas A Wallace; Kristin Robinson; Heather L Howie; Denise A Galloway
Journal:  PLoS Pathog       Date:  2012-07-12       Impact factor: 6.823

10.  Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.

Authors:  Tanya Sperling; Monika Ołdak; Barbara Walch-Rückheim; Claudia Wickenhauser; John Doorbar; Herbert Pfister; Magdalena Malejczyk; Sławomir Majewski; Andrew C Keates; Sigrun Smola
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.